Zephyrnet Logo

Tag: Heart failure

Corvion crowdfunding opportunity project pitch by StartEngine

Funding data (02 April 2024) Raised USD 270,496.24 Min. investment USD 498.75 <!-- --> Details Country United States Type Equity End date 02 July 2024 (-90 days) investors 9 <!-- --> Description “Powering Possibilities for Heart Failure Patients” SEO Powered Content & PR Distribution. Get Amplified...

Top News

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call | BioSpace

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today...

The Weekly Notable Startup Funding Report: 2/26/24

The Weekly Notable Startup Funding Report takes us on a trip across various ecosystems in the US, highlighting some of the notable funding activity...

CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer | BioSpace

Appointment effective February 12 following Nadim Yared’s retirement Hykes currently serves as Augmedics’ President and CEO, and has served on CVRx’s Board of Directors...

Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases – Nature Nanotechnology

Klotter, V. et al. Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: results from a prospective longitudinal cohort study. PLoS...

Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure |...

PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION23 January 2024, 07:00 am CET DSMBi rates DSR 2.0 as safe following review of data from non-randomized cohort Data from...

Austria’s rising stars: 10 innovative startups you must keep an eye on in 2024 and beyond! | EU-Startups

Renowned for its picturesque landscapes and rich cultural heritage, Austria is quickly becoming a hotbed for technological innovation and entrepreneurship. As we step into...

Occlutech(R) Announces FDA Approval of its Occlutech(R) ASD Occluder and Occlutech(R) Pistol Pusher, a Minimally Invasive Cardiac Device and Delivery System to Treat Atrial...

SCHAFFHAUSEN, CH / ACCESSWIRE / January 8, 2024 / Occlutech Holding AG Occlutech ASD Occluder delivers positive procedural outcomes with strong efficacy and a...

A Look Back at India’s Top IP Developments of 2023

.  As 2023 comes to an end, in line with our annual tradition, we take stock of the top IP developments that occurred this year....

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?